title: Adverse Events Following Measles, Mumps, and Rubella Vaccine in Adults Reported to the Vaccine Adverse Event Reporting System (VAERS), 2003-2013.
abstract: BACKGROUND
  Limited data exist on the safety of the measles, mumps, and rubella (MMR) vaccine in adults. We reviewed reports of adverse events (AEs) to the Vaccine Adverse Event Reporting System (VAERS) to assess safety in this previously understudied group.
  
  
  METHODS
  VAERS is the national spontaneous vaccine safety surveillance system coadministered by the Centers for Disease Control and Prevention and the US Food and Drug Administration. We searched the VAERS database for US reports of adults aged ≥19 years who received the MMR vaccine from 1 January 2003 to 31 July 2013. We clinically reviewed reports and available medical records for serious AEs, pregnancy reports, and reports for selected prespecified outcomes.
  
  
  RESULTS
  During this period, VAERS received 3175 US reports after MMR vaccine in adults. Of these, 168 (5%) were classified as serious, including 7 reports of death. Females accounted for 77% of reports. The most common signs and symptoms for all reports were pyrexia (19%), rash (17%), pain (13%), and arthralgia (13%). We did not detect any new safety findings in empirical Bayesian data mining. We identified 131 reports of MMR vaccine administered to a pregnant woman; the majority of these vaccinations were in the first trimester and in 83 (62%), no AE was reported.
  
  
  CONCLUSIONS
  In our review of VAERS data, we did not detect any new or unexpected safety concerns for MMR vaccination in adults. We identified reports of pregnant women exposed to MMR, which is a group in whom the vaccine is contraindicated, suggesting the need for continued provider education on vaccine recommendations and screening.
authors: Immunization Safety Office, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention Emory University School of Medicine, Atlanta, Georgia.
authors: Lakshmi
authors: L
authors: Sukumaran
authors: Immunization Safety Office, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention.
authors: Michael M
authors: MM
authors: McNeil
authors: Immunization Safety Office, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention.
authors: Pedro L
authors: PL
authors: Moro
authors: Immunization Safety Office, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention.
authors: Paige W
authors: PW
authors: Lewis
authors: Office of Biostatistics and Epidemiology, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland.
authors: Scott K
authors: SK
authors: Winiecki
authors: Immunization Safety Office, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention.
authors: Tom T
authors: TT
authors: Shimabukuro
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D018771:Arthralgia / Q000139:chemically induced / Q000453:epidemiology; D002487:Centers for Disease Control and Prevention, U.S.; D064420:Drug-Related Side Effects and Adverse Reactions / Q000453:epidemiology* / Q000473:pathology*; D005076:Exanthema / Q000139:chemically induced / Q000453:epidemiology; D005260:Female; D005334:Fever / Q000139:chemically induced / Q000453:epidemiology; D006801:Humans; D015994:Incidence; D008297:Male; D022542:Measles-Mumps-Rubella Vaccine / Q000008:administration & dosage / Q000009:adverse effects*; D008875:Middle Aged; D010146:Pain / Q000139:chemically induced / Q000453:epidemiology; D011247:Pregnancy; D014481:United States / Q000453:epidemiology; D055815:Young Adult
chemical_list: D022542:Measles-Mumps-Rubella Vaccine
keywords: MMR vaccine; Vaccine Adverse Event Reporting System (VAERS); measles; mumps; rubella
references: Drug Saf. 2013 Jul;36(7):547-56
references: 23657824
references: Vaccine. 2007 Aug 1;25(31):5675-84
references: 17448577
references: MMWR Morb Mortal Wkly Rep. 2014 Jun 6;63(22):496-9
references: 24898167
references: JAMA. 2004 Jul 21;292(3):351-7
references: 15265850
references: Am J Epidemiol. 1979 Aug;110(2):105-23
references: 463869
references: Vaccine. 1991 May;9(5):297-9
references: 1872012
references: MMWR Recomm Rep. 2013 Jun 14;62(RR-04):1-34
references: 23760231
references: Euro Surveill. 2013;18(6). pii: 20395
references: 23410259
references: Ann Intern Med. 2013 Feb 5;158(3):191-9
references: 23358660
references: Am J Obstet Gynecol. 2011 Nov;205(5):473.e1-9
references: 21861964
references: Int J Adolesc Med Health. 2006 Oct-Dec;18(4):615-22
references: 17340852
references: Pediatrics. 1997 Nov;100(5):767-71
references: 9346975
references: Vaccine. 2010 Oct 21;28(45):7248-55
references: 20850534
references: Drug Saf. 2002;25(6):381-92
references: 12071774
references: MMWR Morb Mortal Wkly Rep. 2001 Nov 9;50(44):976-9
references: 11724151
references: Vaccine. 2011 Jan 10;29(3):599-612
references: 20600491
references: Pediatr Infect Dis J. 2004 Apr;23(4):287-94
references: 15071280
references: Pediatrics. 2010 Jul;126(1):e1-8
references: 20587679
references: Pediatrics. 2008 Mar;121(3):e687-92
references: 18310189
references: Vaccine. 2007 Aug 1;25(31):5771-92
references: 17570566
references: Vaccine. 2007 Aug 1;25(31):5717-24
references: 17493712
references: Pediatrics. 2014 Feb;133(2):357-63
references: 24488304